Citadel Advisors - PLUS THERAPEUTICS INC ownership

PLUS THERAPEUTICS INC's ticker is PSTV and the CUSIP is 72941H400. A total of 18 filers reported holding PLUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PLUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$7,000
-92.0%
16,772
-79.8%
0.00%
Q4 2021$87,000
-21.6%
83,149
+91.0%
0.00%
Q2 2021$111,000
+344.0%
43,529
+249.7%
0.00%
Q4 2020$25,000
-56.9%
12,447
-45.1%
0.00%
Q3 2020$58,000
+56.8%
22,659
+45.6%
0.00%
Q4 2019$37,00015,5650.00%
Other shareholders
PLUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 18,318$37,0000.00%
Creative Planning 13,856$28,0000.00%
VANGUARD GROUP INC 21,236$43,0000.00%
UBS Group AG 13$00.00%
TWO SIGMA INVESTMENTS, LP 56,623$114,0000.00%
OSAIC HOLDINGS, INC. 6,003$12,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 30$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 21$00.00%
View complete list of PLUS THERAPEUTICS INC shareholders